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Introduction
As chemokines and adhesion molecules play a major
role in the process by which leukocytes are recruited
from the bloodstream into sites of inflammation [1],
genetic variation in these production or activity mole-
cules may influence susceptibility to inflammatory
diseases [2-4].
Aim
To detect a possible association between the functional
polymorphisms of these molecules and susceptibility to
Crohn’s disease (CD) and ulcerative colitis (UC) in
Tunisian population.
Materials and methods
We have analysed polymorphisms of CCR5-Δ32, CCR5-
59029-A/G, CCR2-V64I, MCP-1 G/A (-2518), ICAM-1
G241R, PECAM-1 V125L, E-selectin L554F and L-selectin
F206L in 194 Inflammatory bowel disease (IBD) patients
and 169 healthy blood donors using PCR-RFLP and PCR-
SSP methods. The patients were classified in 126 patients
with CD and 68 patients with UC.
Results
A significant increase in allele frequency of 206L of
L-selectin was observed in IBD patients compared with
controls (OR: 1.53; 95%CI: [1.05-5.60]; p=0.02) but does
not constitute factor influencing clinical manifestations.
The genotypic and allelic frequencies of chemokine
polymorphisms did not reveal significant differences
between patients and controls, and among CD and UC
patients. However, analysis of CD patients revealed that
those carrying A/A and/or A/G CCR5-59029 genotypes
are more frequently in remission compared to those
with G/G genotype (OR: 0.4; 95%CI: [0.174-0.928];
p=0.03). Also, the frequency of the 64I CCR2 muted
allele was statistically higher in CD patients in remission
disease than those in active form (OR: 0.267; 95%CI:
[0.09-0.78]; p=0.01). Adjustment for known covariates
factors (age, gender and immunosuppressive regimen)
confirmed these univariate findings and revealed that
the A/G CCR5-59029 and V64I CCR2 genotype were
associated to remission form of CD (OR: 2.63 ; 95%CI:
[1.01-6.80] ; p=0.047 and OR: 4.64 ; 95%CI: [1.01-21.31];
p=0.049 respectively).
Conclusion
The present study supports the involvement of chemo-
kine receptor (CCR2 and CCR5) polymorphisms on the
susceptibility to clinical course of IBD in Tunisian
patients. However, further studies are needed to confirm
the association of these diseases with allele L206 of
L-selectin gene.
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